An Infectious cDNA Clone of SARS-CoV-2

Cell Host and Microbe

Volumn 27, Issue 5, 2020, Pages 841-848.e3

  Xie, Xuping ^a   Muruato, Antonio ^a   Lokugamage, Kumari G ^a   Narayanan, Krishna ^a   Zhang, Xianwen ^a   Zou, Jing ^a   Liu, Jianying ^a   Schindewolf, Craig ^a   Bopp, Nathen E ^a   Aguilar, Patricia V ^a,b   Plante, Kenneth S ^a,b   Weaver, Scott C ^a,b   Makino, Shinji ^a,b   LeDuc, James W ^a,b   Menachery, Vineet D ^a,b   Shi, Pei Yong ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

antiviral; coronavirus; COVID 19; SARS CoV; SARS CoV 2; vaccine

Indexed keywords

COMPLEMENTARY DNA; INTERFERON; MOLECULAR MARKER; VIRUS RNA; ANTIVIRUS AGENT;

ANTIVIRAL ACTIVITY; ARTICLE; CORONAVIRUS DISEASE 2019; ELECTROPORATION; MOLECULAR CLONING; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; REPORTER GENE; RNA TRANSCRIPTION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION; ANIMAL; BETACORONAVIRUS; CELL CLONE; CHLOROCEBUS AETHIOPS; CORONAVIRUS INFECTION; GENETICS; PANDEMIC; PATHOGENICITY; PHYSIOLOGY; TRANSGENIC ORGANISM; VERO CELL LINE; VIROLOGY; VIRUS PNEUMONIA;

ANIMALS; ANTIVIRAL AGENTS; BETACORONAVIRUS; CHLOROCEBUS AETHIOPS; CLONE CELLS; CORONAVIRUS INFECTIONS; DNA, COMPLEMENTARY; GENES, REPORTER; GENOME, VIRAL; INTERFERONS; ORGANISMS, GENETICALLY MODIFIED; PANDEMICS; PNEUMONIA, VIRAL; RNA, VIRAL; VERO CELLS; VIRUS REPLICATION;

EID: 85083529350     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2020.04.004     Document Type: Article

References (25)

1. Almazán, F., Sola, I., Zuñiga, S., Marquez-Jurado, S., Morales, L., Becares, M., Enjuanes, L., Coronavirus reverse genetic systems: infectious clones and replicons. Virus Res. 189 (2014), 262–270.
2. Assiri, A., Al-Tawfiq, J.A., Al-Rabeeah, A.A., Al-Rabiah, F.A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W.N., Balkhy, H.H., Al-Hakeem, R.F., et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 13 (2013), 752–761.
3. Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N.G., Decroly, E., The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res., 176, 2020, 104742.
4. Curtis, K.M., Yount, B., Baric, R.S., Heterologous gene expression from transmissible gastroenteritis virus replicon particles. J. Virol. 76 (2002), 1422–1434.
5. de Wit, E., van Doremalen, N., Falzarano, D., Munster, V.J., SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14 (2016), 523–534.
6. Harcourt, J., Tamin, A., Lu, X., Kamili, S., Sakthivel, S.K., Murray, J., Queen, K., Tao, Y., Paden, C.R., Zhang, J., et al. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States. Emerg. Infect. Dis., 2020, 10.3201/eid2606.200516.
7. Holshue, M.L., DeBolt, C., Lindquist, S., Lofy, K.H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al., Washington State 2019-nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States. N. Engl. J. Med. 382 (2020), 929–936.
8. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020), 497–506.
9. Lokugamage, K.G., Hage, A., Schindewolf, C., Rajsbaum, R., Menachery, V.D., SARS-CoV-2 sensitive to type I interferon pretreatment. bioRxiv, 2020, 10.1101/2020.03.07.982264.
10. Menachery, V.D., Yount, B.L. Jr., Debbink, K., Agnihothram, S., Gralinski, L.E., Plante, J.A., Graham, R.L., Scobey, T., Ge, X.Y., Donaldson, E.F., et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat. Med. 21 (2015), 1508–1513.
11. Menachery, V.D., Yount, B.L. Jr., Sims, A.C., Debbink, K., Agnihothram, S.S., Gralinski, L.E., Graham, R.L., Scobey, T., Plante, J.A., Royal, S.R., et al. SARS-like WIV1-CoV poised for human emergence. Proc. Natl. Acad. Sci. USA 113 (2016), 3048–3053.
12. Narayanan, K., Huang, C., Lokugamage, K., Kamitani, W., Ikegami, T., Tseng, C.T., Makino, S., Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J. Virol. 82 (2008), 4471–4479.
13. Schindewolf, C., Menachery, V.D., Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism. Viruses, 11, 2019, E74.
14. Scobey, T., Yount, B.L., Sims, A.C., Donaldson, E.F., Agnihothram, S.S., Menachery, V.D., Graham, R.L., Swanstrom, J., Bove, P.F., Kim, J.D., et al. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 110 (2013), 16157–16162.
15. Shan, C., Xie, X., Muruato, A.E., Rossi, S.L., Roundy, C.M., Azar, S.R., Yang, Y., Tesh, R.B., Bourne, N., Barrett, A.D., et al. An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors. Cell Host Microbe 19 (2016), 891–900.
16. Shaner, N.C., Lambert, G.G., Chammas, A., Ni, Y., Cranfill, P.J., Baird, M.A., Sell, B.R., Allen, J.R., Day, R.N., Israelsson, M., et al. A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum. Nat. Methods 10 (2013), 407–409.
17. Sims, A.C., Baric, R.S., Yount, B., Burkett, S.E., Collins, P.L., Pickles, R.J., Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J. Virol. 79 (2005), 15511–15524.
18. Su, Y.C.F., Anderson, D.E., Young, B.E., Zhu, F., Linster, M., Kalimuddin, S., Low, J.G.H., Yan, Z., Jayakumar, J., Sun, L., et al. Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2. bioRxiv, 2020, 10.1101/2020.03.11.987222.
19. Thao, T.T.N., Labroussaa, F., Ebert, N., V'kovski, P., Stalder, H., Portmann, J., Kelly, J., Steiner, S., Holwerda, M., Kratzel, A., et al. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. bioRxiv, 2020, 10.1101/2020.02.21.959817.
20. Totura, A.L., Baric, R.S., SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr. Opin. Virol. 2 (2012), 264–275.
21. Wu, Z., McGoogan, J.M., Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, 2020, 10.1001/jama.2020.2648.
22. Yount, B., Denison, M.R., Weiss, S.R., Baric, R.S., Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59. J. Virol. 76 (2002), 11065–11078.
23. Yount, B., Curtis, K.M., Fritz, E.A., Hensley, L.E., Jahrling, P.B., Prentice, E., Denison, M.R., Geisbert, T.W., Baric, R.S., Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 100 (2003), 12995–13000.
24. Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., Si, H.R., Zhu, Y., Li, B., Huang, C.L., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579 (2020), 270–273.
25. Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al., China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 382 (2020), 727–733.